GeorgeYaghmourMDFACP

Hematologic Oncology

Associate Director of USC Norris Blood and Marrow Transplant Program at University of Southern California

Dr. Yaghmour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1441 Eastlake Ave
Los Angeles, CA 90089
Phone+1 800-872-2273

Fax+1 323-865-3868

Dr. George Yaghmour is a hematologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC and USC Norris Comprehensive Cancer Center. He received his medical degree from University of Aleppo Faculty of Medicine and has been in practice 11 years. He specializes in hematologic oncology and is experienced in leukemia,lymphoma, Multiple Myeloma, Rare Hematologic disease, Bone marrow failure, and cellular therapy, with advanced skills in stem cell transplantation. He has more than 30 publications and over 150 citings.

PubMed

1 citations
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding.
Amani Alqahtani, Diala Alhousari, Amir Ali, George Yaghmour, Etan Orgel
Expert Opinion on Drug Metabolism & Toxicology. 2023-07-06
171 citations
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Robert Zeiser, Nicola Polverelli, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty
The New England Journal of Medicine. 2021-07-15
12 citations
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia.
Shukaib Arslan, Jianying Zhang, Prajwal Dhakal, Jenna A. Moran, Nuthana Naidoo
American Journal of Hematology. 2021-03-01

Abstracts/Posters

Investigating the Relationship between CD34+and CD3+ Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploi...
George Yaghmour, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Combo Treatment Sans Chemotherapy Effective for Ph+ ALL ElderlyDecember 12th, 2023